The 3020insC NOD2 gene mutation in patients with ovarian cancer

Ginekologia Polska

Volumn 79, Issue 8, 2008, Pages 544-549

  Magnowski, Piotr ^a   Medrek, Krzysztof ^b   Magnowska, Magdalena ^a   Stawicka, Małgorzata ^c   Kedzia, Helena ^d   Górski, Bohdan ^b   Lubiński, Jan ^b   Spaczyński, Marek ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b POMERANIAN MEDICAL UNIVERSITY   (Poland)

^c Prophylactic and Epidemiology Center   (Poland)

^d GPSK UM ^*  (Poland)

Author keywords

NOD2; Ovarian cancer

Indexed keywords

EID: 54149108413     PISSN: 00170011     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Hugot J, Laurent-Puig P, Gower-Rousseau C, [et al.]. Mapping of a susceptibility locus for Crohns disease no chromosome 16. Nature. 1996, 379, 821-823.
2. Inohara N, Nuoez G. NODs: intracellular proteins involved in inflammation and apoptosis. Nat Rev Immunol. 2003, 3, 371-382.
3. Hampe J, Cuthbert A, Croucher P, [et al.]. Associacion between insertion mutation in NOD2 gene and Crohns disease in German and British population. Lancet. 2001, 357, 1925-1928.
4. Inohara N, Ogura Y, Chen F, [et al.]. Human NOD1 confers responsiveness to bacterial lipopolysaccharides. J Biol Chem. 2001, 276, 2551-2554.
5. King K, Sheikh M, Cuthbert A, [et al.]. Mutation selection and evolution of the Crohn disease susceptibility gene CARD15. Hum Mutat. 2006, 27, 44-54.
6. Van Der Woude C, Kleibeukar J, [et al.]. Chronic inflammation, apoptosis and (pre-) malignant lesions in gastrointestinal tract. Apoptosis. 2004, 9, 123-130.
7. Wright J, Christman J. The role of nuclear factor kappa B in the pathogenesis of pulmonary diseases: implications for therapy. Am J Respir Med. 2003, 2, 211-219.
8. Liu J, Yang G, Thompson-Lanza J, [et al.]. A genetically defined model for human ovarian cancer. Cancer Res. 2004, 1, 1655-1663.
9. Huang S, Robinson J, Deguzman A, [et al.]. Blockade of nuclear factor-kappa B signaling inhibits angiogenesis and tumorigencity of human ovarian cancer cells by suppressing expression of vascular endothelial growth factor and interleukin 8. Cancer Res. 2000, 60, 5334-5339.
10. Górski B, Cybulski C, Huzarski T, [et al.]. Breast cancer predisposing allele in Poland. Breast Cancer Res Treat 2005, 92, 19-24.
11. Lubiński J, Huzarski T, Kurzawski G, [et al.]. The 3020insC allele of NOD2 predispose to cancer of multiple organs. Hered Cancer Clin Pract. 2005, 3, 59-63.
12. Górski B, Byrski T, Huzarski T, [et al.]. Founder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer. Am J Hum Genet. 2000, 66, 1963-1968.
13. Papaconstatiou I, Theodoropoulos G, Gazouli M, [et al.]. Associacion between mutations in the CARD15/NOD2 gene and colorectal cancer in a Greek population. Int J Cancer. 2005, 114, 433-435.
14. Alhopuro P, Ahvenainen T, Mecklin J, [et al.]. NOD2 3020insC alone is not sufficient for colorectal cancer predisposition. Cancer Res. 2004, 64, 7245-7247.
15. Lubiński J, Huzarski T, Kurzawski G, [et al.]. The 3020insC allele of NOD2 predispose to cancer of multiple organs. Hered Cancer Clin Pract. 2005, 3, 59-63.
16. Debniak T, Cybulski C, Kurzawski G, [et al.]. Low-risk genes and multi-organ cancer risk in the polish population. Hered Cancer Clin Pract. 2006, 4, 52-55.
17. Janiszewska H, Haus O, Lauda-Świeciak A, [et al.]. The NOD2 3020insC mutation in women with breast cancer from the Bydgoszcz region in Poland. First results. Hered Cancer Clin Pract. 2006, 4, 15-19.
18. Kurzawski G, Suchy J, Kładny J, [et al.]. The NOD2 3020insC mutation and the risk of colorectal cancer. Cancer Res. 2004, 64, 1604-1606.
19. Irejs A, Miklasevics E, Boroschenko V, [et al.]. Pilot study on low penetrance breast and colorectal cancer predisposition markers in Latvia. Hered Cancer Clin Pract. 2006, 4, 48-51.